SAMRAT PHARMACHEM
Back to Income Statement
|
SAMRAT PHARMACHEM Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹286 Cr | ₹282 Cr | ₹311 Cr | ₹222 Cr | ₹179 Cr |
What is the latest Revenue of SAMRAT PHARMACHEM ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹286 Cr |
| Mar2024 | ₹282 Cr |
| Mar2023 | ₹311 Cr |
| Mar2022 | ₹222 Cr |
| Mar2021 | ₹179 Cr |
How is Revenue of SAMRAT PHARMACHEM Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹286 Cr | 1.52 | |
| Mar2024 | ₹282 Cr | -9.36 | |
| Mar2023 | ₹311 Cr | 40.09 | |
| Mar2022 | ₹222 Cr | 23.87 | |
| Mar2021 | ₹179 Cr | - | |
Compare Revenue of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹63.1 Cr | -2.4% | -2.8% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -2.4% |
-2.8% |
-38.8% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses